Harmony Biosciences Holdings, Inc. (HRMY)
NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
Show:
Annual
Cash flow
All numbers in thousandsBreakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Cash flows from operating activities
Net income
137,702
128,853
181,468
34,597
-36,944
-
Depreciation & amortisation
24,419
24,359
23,385
18,840
10,237
-
Deferred income taxes
-13,454
-13,419
-85,943
0
-
-
Stock-based compensation
34,896
31,705
26,173
15,659
4,693
-
Change in working capital
10,966
35,035
-4,106
631
-11,628
-
Accounts receivable
-27,144
-19,400
-19,897
-12,667
-17,922
-
Inventory
-1,767
-1,066
135
-609
-2,735
-
Accounts payable
3,735
8,949
2,785
-1,555
-3,804
-
Other working capital
207,652
219,075
104,294
-1,741
-4,987
-
Other non-cash items
6,347
5,803
3,921
2,684
4,909
-
Net cash provided by operating activities
207,969
219,387
144,466
98,557
-2,985
-
Cash flows from investing activities
Investments in property, plant and equipment
-
-312
-40,172
-100,298
-2,002
-
Acquisitions, net
-
-36,967
0
0
-
-
Purchases of investments
-104,799
-127,469
-110,729
0
-
-
Sales/maturities of investments
91,248
118,309
9,069
0
-
-
Net cash used for investing activities
-50,835
-46,439
-141,832
-100,298
-2,002
-
Cash flows from financing activities
Debt repayment
-204,500
-201,250
-2,000
-200,500
-120,585
-
Common stock issued
-
0
0
30,000
147,628
-
Common stock repurchased
-
-100,000
0
0
-167
-
Other financing activities
-
-9,357
-
-31,452
-18,014
-6,316
Net cash used provided by (used for) financing activities
-112,595
-105,552
6,841
7,419
209,161
-
Net change in cash
44,539
67,396
9,475
5,678
204,174
-
Cash at beginning of period
288,712
244,534
235,059
229,381
25,207
-
Cash at end of period
333,251
311,930
244,534
235,059
229,381
-
Free cash flow
Operating cash flow
207,969
219,387
144,466
98,557
-2,985
-
Capital expenditure
-
-312
-40,172
-100,298
-2,002
-
Free cash flow
207,652
219,075
104,294
-1,741
-4,987
-
© 2024 Yahoo. All rights reserved.